We have already shown that AS can be deleted in Pb8 and it would be of interest to examine its requirement in Pf. Like GS, AS is being explored for cancer therapy, and adenylated sulfoximines and methylsulfoximines are shown to be potential inhibitors of AS66. This evidence concerns the gene GLUL and cancer.